TB doesn't discriminate, affecting over 10 million people annually. It's a leading cause of death among those with HIV and major driver of maternal mortality. Unitaid is on the frontline, bringing solutions to the most vulnerable.

Find out more: unitaid.org/news-blog/over…

Babies born prematurely may suffer health complications requiring oxygen. In partnership with Vayu Global Health, Unitaid provided 25 Ukrainian hospitals with 220 continuous positive airway pressure (CPAP) devices and 125 oxygen mixture systems.

Learn more: news.un.org/en/story/2022/…

'Strengthening oxygen systems could cut hospital-based pneumonia deaths among children by half,' say @Unitaid's Dr Philippe Duneton, Japanese Ambassador Takeshi Akahori (@MofaJapan_en) & Ministry of Health's Dr. Patrick Amoth, EBS.

Invest in children's lives, #InvestInOxygen :
asia.nikkei.com/Opinion/Need-t…

The synergy between World Health Organization (WHO)'s TB preventive treatment goals and Unitaid's investments in pediatric MDR-TB prevention research is unmistakable. Together, we're working towards a future where TB no longer threatens children's lives.

Find out more: unitaid.org/news-blog/new-…

The Unitaid-funded GLAD project, led by University of Washington, is developing monthly injectables to replace daily pills, making adherence easier and reducing drug resistance.

Read how this could change the lives of those living with HIV in low- and middle-income countries: spotlightnsp.co.za/2023/11/14/in-…

Le secteur de la santé, avec 4,6 % des émissions mondiales de CO2, doit innover pour rester durable. Une étude d'Unitaid révèle comment réduire ces émissions et protéger notre futur : lagrandeconversation.com/ecologie/les-s…

Kenyan children at risk of tuberculosis will benefit from a new formulation, developed through the Unitaid-funded IMPAACT4TB consortium, which offers shorter and cheaper formulations for children.

Find out more: the-star.co.ke/counties/nairo…

Did you know? Over 400,000 people developed multidrug-resistant TB (MDR-TB) in 2022. Our latest research brings hope, revealing levofloxacin's potential in preventing this deadly disease.

Find out more: devex.com/news/study-com…

Félicitations AMPROU Anne-Claire et merci pour votre engagement sans faille pour la santé mondiale !

Africa's emerging pharmaceutical manufacturing capabilities present a timely opportunity to support the continent's health needs. Unitaid's report highlights key advancements.

Read our report: unitaid.org/assets/Antimal…

Investing in HIV, TB & malaria sees a 16% higher return in health & economic benefits when backed by innovations like those pioneered by Unitaid & scaled up by the The Global Fund. Together, we're advancing global health goals and saving lives faster.

👇
unitaid.org/news-blog/part…

Récemment, l'Union européenne 🇪🇺 investit 20M€ dans la lutte contre l'hémorragie post-partum en Afrique avec Unitaid & UNFPA. Objectif : zéro décès maternel. Un grand pas vers un futur où chaque accouchement est sûr! Belgian Presidency of the Council of the EU 2024

🔗 unitaid.org/news-blog/join…

Meet Busisiwe Beko, a survivor of drug-resistant TB and HIV, who faced her toughest battle during pregnancy. Her story underscores the critical need for accessible TB prevention and care.

Read Busi's journey: unitaid.org/news-blog/over…

By boosting regional antimalarial manufacturing, Africa can strengthen health security and make strides towards universal health coverage and Sustainable Development Goals.

Find out more: unitaid.org/news-blog/new-…

Progress in the malaria fight has plateaued globally, but Unitaid remains dedicated to overcoming health system challenges, funding shortfalls, and biological threats to advance the response.

Discover how Unitaid is fighting malaria: unitaid.org/assets/Unitaid…

Dr. Ethel Weld presents encouraging findings from the 'Dolphin-Too' trial, confirming the safety and efficacy of combining DTG-based ARVs with TB prevention drugs 3HP.

Find out more: the-star.co.ke/health/2024-03…

Through lived experiences, we find powerful solutions. Oleksiy's story shows why Unitaid & partners like Frontline AIDS, International Network of People who Use Drugs, Médecins du Monde & PATH invest in community-driven approaches in research design for #HepatitisC treatment & prevention among people who use drugs.

A Unitaid-funded study represents 'a major breakthrough that could potentially protect millions of children from [tuberculosis],' said Unitaid's Executive Director, Dr Philippe Duneton.

Find out more: euronews.com/next/2023/11/1…

TB-CHAMP, co-financée par Unitaid, est la 1ère étude majeure informant la prévention infantile de la TB-MR. Selon Dr Philippe Duneton, il s'agit d'une avancée majeure qui pourrait aboutir à protéger des millions d’enfants face à cette maladie.

Pour en savoir plus: liberation.fr/societe/sante/…

Celebrating 10 years of transforming HIV treatment! With our support, MedicinesPatentPool and ViiV Healthcare have ensured access to life-saving dolutegravir to millions in LMICs, saving billions in healthcare costs. We're proud to support this partnership 🤝